On Monday, UroGen Pharma Priced The Public Offering Of 5M Shares At $17.50/Share, Pre-funded Warrants To Purchase 1.14M Shares At $17.499/Pre-funded Warrant, With Gross Proceeds Of Approximately $107.5M
On Monday, UroGen Pharma Priced The Public Offering Of 5M Shares At $17.50/Share, Pre-funded Warrants To Purchase 1.14M Shares At $17.499/Pre-funded Warrant, With Gross Proceeds Of Approximately $107.5M
週一，UroGen Pharma以17.50美元/股的價格定價公開發行了500萬股普通股和預先融資認股權，以17.499美元/預先融資認股權購買1.14萬股普通股，募集總收入約爲1.075億美元。
On Monday, UroGen Pharma Priced The Public Offering Of 5M Shares At $17.50/Share, Pre-funded Warrants To Purchase 1.14M Shares At $17.499/Pre-funded Warrant, With Gross Proceeds Of Approximately $107.5M
週一，UroGen Pharma以17.50美元/股的價格定價公開發行了500萬股普通股和預先融資認股權，以17.499美元/預先融資認股權購買1.14萬股普通股，募集總收入約爲1.075億美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。